Nurix Therapeutics NRIX
NASDAQ NRIX
$23.71 +0.04 (+0.17%)
At close: Sep 30, 2026 · 4:00 PM EDT

Nurix Therapeutics (NRIX) Preferred Stock Liabilities (2019 - 2020)

Updated

Nurix Therapeutics' Preferred Stock Liabilities was $168.11 million in fiscal Q2 2020 (quarter ended May 31, 2020), up 248.8% from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends

At the end of FY2019 (ended Nov 30, 2019), Preferred Stock Liabilities at Nurix Therapeutics came in at $48.2 million.

  • Per Business Quant data, NRIX's Preferred Stock Liabilities in the three fiscal quarters before Q2 2020 was $48.2 million (Q1 2020), $48.2 million (Q4 2019) and $48.2 million (Q3 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Nurix Therapeutics 2.46 Bn 452.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2020 168.11 Mn
Feb 29, 2020 48.20 Mn
Nov 30, 2019 48.20 Mn
Aug 31, 2019 48.20 Mn
API Access

Nurix Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=NRIX&period=max&api_key=YOUR_API_KEY